Picture of Johnson & Johnson logo

JNJ — Johnson & Johnson News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

US FDA expands approval for J&J's drug for rare blood disorder

US FDA expands approval for J&J's drug for rare blood disorder

- The U.S. Food and Drug Administration has approved the expanded use of Johnson & Johnson's JNJ.N drug to treat a rare blood disorder, the company said on Monday.




(Reporting by Kunal Das and Padmanabhan Ananthan in Bengaluru; Editing by Vijay Kishore)

((Kunal.Das2@thomsonreuters.com;))

Recent news on Johnson & Johnson

See all news